跳至主要内容
临床试验/CTRI/2025/11/096832
CTRI/2025/11/096832
尚未招募
3 期

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF BHAVAPRAKASHOKTA SHEPHALIKA PATRA KASHAYAM AND RASNA GUGGULU IN GRIDHRASI W.S.R. TO SCIATICA

Govt ayurveda college nipaniya rewa mp1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年4月30日最近更新:

概览

阶段
3 期
状态
尚未招募
发起方
Govt ayurveda college nipaniya rewa mp
入组人数
40
试验地点
1
主要终点
improvement in subjective parameters like Ruk Stambh Tod Muhuspandana Graha Aruchi Tandra Gaurava

概览

简要总结

The present clinical study entitled A Comparative Clinical Study to Evaluate the Efficacy of Bhavaprakashokta Shephalika Patra Kashayam and Rasna Guggulu in Gridhrasi w.s.r. to Sciatica aims to evaluate and compare the therapeutic effects of two classical Ayurvedic formulations in the management of Gridhrasi, a Vatavyadhi closely correlated with sciatica.

Gridhrasi is characterized by  Ruka   Stambha Toda Muhuspandanaand  Sakthikshepa Nigrahaoften accompanied by Tandra, Gaurava, and Arochaka in Kaphanubandha type. The condition corresponds to the modern entity “sciatica,” involving radiating pain along the sciatic nerve due to compression or irritation.

The study is designed as a prospective, open-labelled, randomized clinical trial conducted on 40 patients, divided into two groups of 20 each.

Group A Shephalika Patra Kashayam   50 ml twice daily before meals

Group BRasna Guggulu   250 mg twice daily after meals

The treatment duration is 30 days, with a follow-up of 15 days, and both groups receive Ushna Jala as Anupana.

Both formulations are selected for their Vata-Kapha Shamak, Vedanasthapana, Amapachaka, and Shothahara properties.

Shephalika Patra Kashayam *Vitex negundo Linn.*possesses Ushna Veerya and Katu Vipaka, aiding in pain and inflammation reduction and Amapachana.

Rasna Guggulu combines Rasna Pluchea lanceolataand Guggulu  Commiphora mukul providing potent Vatashamaka, anti-inflammatory, and analgesic actions.

This study seeks to establish a comparative evaluation of these two Ayurvedic regimens to determine which provides better relief in terms of pain, stiffness, and functional improvement, thereby offering an effective, safe, and economical alternative for the management of Gridhrasi

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients aged between 16 to 70 years of any gender 2.Patients having clinical signs and symptoms of Gridhrasi 3.Patients willing to sign the informed consent form
  • SLR (Straitght Leg Raising) Test positive.

排除标准

  • Pregnancy & Lactating women
  • Tuberculosis of spine
  • Diabetes mellitus
  • Cardiac Disease
  • Congenital Disease
  • Traumatic injury.

结局指标

主要结局

improvement in subjective parameters like Ruk Stambh Tod Muhuspandana Graha Aruchi Tandra Gaurava

时间窗: on 0 days to 30 days

次要结局

  • improvement in subjective parameters like Ruk Stambh Tod Muhuspandana Graha Aruchi(on 0 days to 30 days)

研究者

发起方
Govt ayurveda college nipaniya rewa mp
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Jitendra Patel

Govt ayurveda college nipaniya rewa mp

研究点 (1)

Loading locations...

相似试验